Forbion European Acquisition Corp.

Forbion European Acquisition Corp. (Nasdaq: FRBN) is a blank-check company sponsored by Forbion, a prominent European life sciences venture capital firm headquartered in the Netherlands with a long track record of backing biotech and healthcare companies. The SPAC completed its initial public offering in 2021 and was structured to target acquisition opportunities in the European life sciences and biopharmaceutical sector. A Form 425 filed with the SEC on October 24, 2023 reflects communications related to a proposed business combination, indicating the vehicle was in an active de-SPAC process at that time. For complete filing history, deal terms, and real-time status updates on FRBN, sign up for full data access at SpacDesk.